Triumeq
Abacavir, Dolutegravir, Lamivudine
600/50/300mg
Indicated for HIV infection to support viral suppression.
From $8.69 / tablet View
HIV Management
Antiretroviral medicines can be used to treat HIV or, in specific combinations, to prevent acquisition. Treatment, pre-exposure prophylaxis and post-exposure prophylaxis are different pathways and require HIV testing and clinical follow-up.
Tenofovir Emtricitabine
300/200mg
Intended to relieve viral replication in human immunodeficiency virus infection to support immune stability.
From $1.84 / tablet View
Epivir Hbv
100mg
Indicated for chronic hepatitis b to support viral suppression and hepatocyte health.
From $1.73 / tablet View
Darunavir Tablets
600 · 800mg
Developed to target human immunodeficiency virus infection to support immune system health.
From $9.35 / tablet View
Natdac
Tenofovir Disoproxil, Daclatasvir, Sofosbuvir
60mg
Indicated to manage hepatitis c to mitigate viral infection.
From $6.26 / tablet View
Key takeaways
- HIV treatment uses a planned regimen; taking one medicine alone or switching individual components can lead to treatment failure or resistance.
- PrEP is for people confirmed not to have HIV, while PEP is a time-sensitive option after a recent possible exposure.
- A new rash with fever, breathing difficulty, jaundice or severe weakness after starting medicine needs urgent assessment.
The listings are for comparison; suitability and supply depend on clinician and pharmacy checks, stock, destination rules and any prescription requirements.
How the medicine groups differ
- Nucleoside or nucleotide components: tenofovir disoproxil, lamivudine and abacavir may form part of a combination selected after clinical checks.
- Integrase inhibitors: dolutegravir and raltegravir block a different stage of viral replication and are used with other active medicines.
What these medicines are used for
The category includes medicines used for HIV infection and pre-exposure prophylaxis. Some components also have a role in chronic hepatitis B, which changes how they should be started or stopped.
Important safety checks
HIV status, kidney and liver function, hepatitis B status, pregnancy and medicine interactions should be reviewed. Do not stop treatment or HBV-active medicine without clinical advice; interruption can allow HIV to rebound or hepatitis B to flare.
When to seek urgent care
Seek prompt clinical care after a recent possible HIV exposure because PEP is time-sensitive. Get urgent help for breathing difficulty, facial swelling, a widespread rash with fever, jaundice, severe abdominal pain or marked weakness.